Triple-Negative Breast Cancer: Susan's Patient Story
This breast cancer diagnosis at a glance
- Biomarkers
- BRCA negative; earlier breast cancer described as triple-negative; later breast cancer estrogen-positive and progesterone-positive; HER2 not reported
- Sex
- Female
- Treatment
- surgery, chemotherapy, radiation and hormone therapy
- Outcome
- Care Ongoing
Treatment course, step by step
- Initial left breast cancer in 2000: surgical removal after fine needle aspiration was falsely negative
- MD Anderson lumpectomy/additional margin surgery with sentinel node biopsy; 5 lymph nodes negative
- IV chemotherapy, 6 treatments given every 3 weeks; regimen name not recalled
- 6.5 weeks of radiation
- mammograms every 6 months, then annually, with long-term negative follow-up. Later breast cancer in 2021: mammogram and biopsy after nipple change; estrogen-positive and progesterone-positive, not metastatic
- bilateral mastectomy with aesthetic flat closure and nipple removal because the tumor was under the nipple
- 5-year estrogen blocker.
What happened, in summary
Susan was 72 when she shared a long history with breast cancer. Her first diagnosis began in 2000, when her husband, a physician, felt a small hard lump in her left breast. A fine needle aspiration missed the cancer 3 times, but surgical removal showed the lump was malignant. At MD Anderson, Susan had a lumpectomy with additional margin surgery and sentinel node biopsy. Five lymph nodes were removed and all were negative. Her oncologist recommended chemotherapy and radiation. She received 6 IV chemotherapy treatments 3 weeks apart, though she no longer remembered the regimen name. Anti-nausea medicines caused allergic reactions early on, and one treatment was especially hard when antiemetics were missed. She then completed 6.5 weeks of radiation and continued follow-up mammograms every 6 months, then yearly. The results stayed negative, and 10 years later she celebrated a cancer-free anniversary. In 2015, Susan was diagnosed with Parkinson’s disease. In 2021, a change in the appearance of her nipple led to mammogram and biopsy. This cancer was different: estrogen-positive and progesterone-positive, and not metastatic. Susan chose bilateral mastectomy without reconstruction, with aesthetic flat closure, because the tumor was under the nipple. As of August 2023, she was on a 5-year estrogen blocker and continuing to adjust emotionally to life after surgery.
Where this story comes from
This is a lay summary of an account first published by The Patient Story. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer